ISI Group

Evercore ISI, formerly known as ISI Group (International Strategy & Investment), is a leading independent investment banking advisory firm and a powerhouse in healthcare and biotechnology equity research. The firm is widely recognized for its deep fundamental analysis of the life sciences sector, providing critical insights to institutional investors on drug development, regulatory milestones, and market dynamics. Following its acquisition by Evercore in 2014, the ISI Group research team has consistently ranked at the top of Institutional Investor surveys, particularly in the Biotechnology and Pharmaceuticals categories. While not a drug developer itself, Evercore ISI plays a pivotal role in the biotech ecosystem by facilitating capital raises, providing M&A advisory, and shaping investor sentiment through its influential research reports.